0
0
Home » Medical Devices » ENT Devices

Hearing Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Hearing implants are electronic devices implanted into the ear of a deaf or hard to hear person. These devices transmit sound from the ear to the brain. GlobalData's Medical Devices sector report, “Hearing Implants – Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Hearing Implants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Hearing Implants report provides key information and data related to:

Extensive coverage of the Hearing Implants under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Hearing Implants pipeline products.

Review of Recent Developments in the segment / industry

The Hearing Implants report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Hearing Implants under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Hearing Implants – Medical Devices Pipeline Product Landscape, 2021” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

Extensive coverage of the Hearing Implants under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Hearing Implants and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Hearing Implants under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Players

Advanced Bionics AG

Advanced Bionics LLC

Auritec Pharmaceuticals Inc

Ceragenix Pharmaceuticals, Inc. (Inactive)

Cochlear Ltd

Demant A/S

Ecole Polytechnique Federale de Lausanne

Envoy Medical Corp

Hannover Medical School

Hemideina Solution

Huntington Medical Research Institutes

Labyrinth Devices

MED-EL Elektromedizinische Gerate Gesellschaft mbH

Northwestern University

Oticon Medical AB

OtoKinetics Inc

Ototronix, LLC

Sonova Holding AG

SpecialtyCare Inc

Tel Aviv Sourasky Medical Center

The University of Nottingham

Trinity College Dublin

University of Florida

University of Michigan Pediatric Device Consortium

University of Oklahoma

University of South Florida

University of Utah

University of Wisconsin Madison

Table of Contents

1 Table of Contents

2 Introduction 9

2.1 Hearing Implants Overview 9

3 Products under Development 10

3.1 Hearing Implants – Pipeline Products by Stage of Development 10

3.2 Hearing Implants – Pipeline Products by Segment 11

3.3 Hearing Implants – Pipeline Products by Territory 12

3.4 Hearing Implants – Pipeline Products by Regulatory Path 13

3.5 Hearing Implants – Pipeline Products by Estimated Approval Date 14

3.6 Hearing Implants – Ongoing Clinical Trials 15

4 Hearing Implants – Pipeline Products under Development by Companies 16

4.1 Hearing Implants Companies – Pipeline Products by Stage of Development 16

4.2 Hearing Implants – Pipeline Products by Stage of Development 18

5 Hearing Implants Companies and Product Overview 19

5.1 Advanced Bionics AG Company Overview 19

5.1.1 Advanced Bionics AG Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 Advanced Bionics LLC Company Overview 20

5.2.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 Auritec Pharmaceuticals Inc Company Overview 21

5.3.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 22

5.4.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 22

5.5 Cochlear Ltd Company Overview 23

5.5.1 Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.6 Demant A/S Company Overview 29

5.6.1 Demant A/S Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 Ecole Polytechnique Federale de Lausanne Company Overview 30

5.7.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Envoy Medical Corp Company Overview 31

5.8.1 Envoy Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 Hannover Medical School Company Overview 32

5.9.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 32

5.10 Hemideina Solution Company Overview 33

5.10.1 Hemideina Solution Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 Huntington Medical Research Institutes Company Overview 34

5.11.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 34

5.12 Labyrinth Devices Company Overview 35

5.12.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 MED-EL Elektromedizinische Gerate Gesellschaft mbH Company Overview 38

5.13.1 MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 Northwestern University Company Overview 42

5.14.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 42

5.15 Oticon Medical AB Company Overview 43

5.15.1 Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 43

5.16 OtoKinetics Inc Company Overview 44

5.16.1 OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.17 Ototronix, LLC Company Overview 45

5.17.1 Ototronix, LLC Pipeline Products & Ongoing Clinical Trials Overview 45

5.18 Sonova Holding AG Company Overview 46

5.18.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 46

5.19 SpecialtyCare Inc Company Overview 48

5.19.1 SpecialtyCare Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.20 Tel Aviv Sourasky Medical Center Company Overview 49

5.20.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 49

5.21 The University of Nottingham Company Overview 50

5.21.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 50

5.22 Trinity College Dublin Company Overview 51

5.22.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 51

5.23 University of Florida Company Overview 52

5.23.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 52

5.24 University of Michigan Pediatric Device Consortium Company Overview 53

5.24.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 53

5.25 University of Oklahoma Company Overview 54

5.25.1 University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview 54

5.26 University of South Florida Company Overview 55

5.26.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 55

5.27 University of Utah Company Overview 56

5.27.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 56

5.28 University of Wisconsin Madison Company Overview 57

5.28.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 57

6 Hearing Implants- Recent Developments 58

6.1 Jun 15, 2021: Sonova shareholders approve all motions of the Board of Directors 58

6.2 May 27, 2021: OU Board of Regents Elects Cawley, Keating as Officers 58

6.3 May 18, 2021: Sonova continues to outpace the market and achieves strong growth in the second half-year 59

6.4 May 03, 2021: GN Hearing introduces Interton Move, an essential hearing aid portfolio to help people get more out of life 64

6.5 Apr 02, 2021: Hearing aid aesthetics: how the appearance of devices can impact adherence 65

6.6 Mar 18, 2021: Cochlear announces next phase in development of a cochlear implant with drug eluting electrode technology 66

6.7 Mar 11, 2021: Dr. Neil Hattangadi Joins Intersect ENT’s Board of Directors 66

6.8 Feb 23, 2021: Will Weatherford elected vice chair of the USF Board of Trustees 67

6.9 Feb 23, 2021: Intersect ENT to Report Fourth Quarter and Full Year 2020 Financial Results 67

6.10 Feb 17, 2021: St. Petersburg Conference on World Affairs to provide global perspective and insight into historic turmoil 68

6.11 Feb 12, 2021: Olympus reports 9M results 68

6.12 Feb 12, 2021: Cochlear Appoints Stu Sayers as CFO 69

6.13 Feb 01, 2021: Intersect ENT to Participate in Upcoming Investor Conferences 69

6.14 Jan 05, 2021: Intersect ENT to Present at the 39th Annual J.P. Morgan Healthcare Conference 69

6.15 Nov 02, 2020: Elos Medtech investing to meet increased demand in robotic surgery 69

6.16 Oct 19, 2020: University of Sydney research could lead to customised cochlear implants 70

6.17 Aug 06, 2020: Team to create customizable cochlear implant programming 71

7 Appendix 73

7.1 Methodology 73

7.2 About GlobalData 76

7.3 Contact Us 76

List of Tables

Hearing Implants – Pipeline Products by Stage of Development 10

Hearing Implants – Pipeline Products by Segment 11

Hearing Implants – Pipeline Products by Territory 12

Hearing Implants – Pipeline Products by Regulatory Path 13

Hearing Implants – Pipeline Products by Estimated Approval Date 14

Hearing Implants – Ongoing Clinical Trials 15

Hearing Implants Companies – Pipeline Products by Stage of Development 16

Hearing Implants – Pipeline Products by Stage of Development 18

Advanced Bionics AG Pipeline Products & Ongoing Clinical Trials Overview 19

Naida CI Marvel Sound Processor – Product Status 19

Naida CI Marvel Sound Processor – Product Description 19

Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 20

Hires Fidelity 120 Pediatrics – Product Status 20

Hires Fidelity 120 Pediatrics – Product Description 20

Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Steroid Eluting Cochlear Implant – Product Status 21

Steroid Eluting Cochlear Implant – Product Description 21

Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 22

Cerashield Coated Cochlear Inner Ear Implant – Product Status 22

Cerashield Coated Cochlear Inner Ear Implant – Product Description 22

Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Nucleus 7 Sound Processor For Nucleus 22 Implant – Product Status 23

Nucleus 7 Sound Processor For Nucleus 22 Implant – Product Description 24

Nucleus Kanso 2 Sound Processor – Product Status 24

Nucleus Kanso 2 Sound Processor – Product Description 24

Nucleus Profile Plus – Product Status 25

Nucleus Profile Plus – Product Description 25

OSIA 2 System – Product Status 25

OSIA 2 System – Product Description 26

Cochlear Ltd – Ongoing Clinical Trials Overview 27

OSIA 2 System – A Multicentre, Open, Long-term Clinical Investigation Evaluating Safety, Performance and Patient Reported Outcomes with an Active Osseointegrated Steady-State Implant System in Adult Subjects with Conductive Hearing Loss, Mixed Hearing Loss or Single-sided Sensorineural Deafness 28

OSIA 2 System – A Post-market Interventional Cohort Study Evaluating the Clinical Efficacy of the Osia 2 System in the US Market 28

Demant A/S Pipeline Products & Ongoing Clinical Trials Overview 29

Neuro 2 – Product Status 29

Neuro 2 – Product Description 29

Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 30

Soft Auditory Brainstem Implant – Product Status 30

Soft Auditory Brainstem Implant – Product Description 30

Envoy Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 31

Acclaim Cochlear Implant – Product Status 31

Acclaim Cochlear Implant – Product Description 31

Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 32

Optical Cochlea Stimulator – Product Status 32

Optical Cochlea Stimulator – Product Description 32

Hemideina Solution Pipeline Products & Ongoing Clinical Trials Overview 33

Hera Wireless Implant Device – Product Status 33

Hera Wireless Implant Device – Product Description 33

Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 34

Multisite Device – Product Status 34

Multisite Device – Product Description 34

Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 35

MVI Vestibular Implant System – Product Status 35

MVI Vestibular Implant System – Product Description 35

Labyrinth Devices – Ongoing Clinical Trials Overview 36

MVI Vestibular Implant System – First-in-human Early Feasibility Study of Safety, Tolerability and Efficacy for a Multichannel Vestibular Implant in Individuals with Bilateral Severe-to-profound Loss of Vestibular Sensation 37

MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview 38

Totally Implantable Cochlear Implant (TICI) – Product Status 38

Totally Implantable Cochlear Implant (TICI) – Product Description 38

MED-EL Elektromedizinische Gerate Gesellschaft mbH – Ongoing Clinical Trials Overview 39

Auditory Nerve Test System – Feasibility of Auditory Nerve Test System for Optimization of Simultaneous Translabyrinthine Vestibular Schwannoma Resection with Cochlear Implantation 40

Totally Implantable Cochlear Implant (TICI) – Feasibility Study: A Totally Implantable Cochlear Implant (Mi2000) for Electrical Stimulation of the Auditory Pathway of Adults with Severe to Profound Sensorineural Hearing Loss 41

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 42

Cochlear Implant – Product Status 42

Cochlear Implant – Product Description 42

Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 43

Next Generation Transcutaneous Bone Conduction Device – Product Status 43

Next Generation Transcutaneous Bone Conduction Device – Product Description 43

OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Krescendo I – Product Status 44

Krescendo I – Product Description 44

Ototronix, LLC Pipeline Products & Ongoing Clinical Trials Overview 45

Dalhousie Hearing Device – Product Status 45

Dalhousie Hearing Device – Product Description 45

Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 46

Ingenia – Product Status 46

Ingenia – Product Description 46

Next Generation Cochlear Implant – Product Status 47

Next Generation Cochlear Implant – Product Description 47

SpecialtyCare Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Miniature Middle Ear Implant – Product Status 48

Miniature Middle Ear Implant – Product Description 48

Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 49

Implant Electrode Extender – Product Status 49

Implant Electrode Extender – Product Description 49

The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 50

Antibiotic Pellet – Product Status 50

Antibiotic Pellet – Product Description 50

Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 51

Closed-loop Cochlear Implant – Product Status 51

Closed-loop Cochlear Implant – Product Description 51

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 52

Adjustable Middle Ear Prosthesis Device – Product Status 52

Adjustable Middle Ear Prosthesis Device – Product Description 52

University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 53

Enhanced Cochlear Implant Device – Product Status 53

Enhanced Cochlear Implant Device – Product Description 53

University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview 54

Totally Implantable Hearing System – Product Status 54

Totally Implantable Hearing System – Product Description 54

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 55

Promontory Anchored Incus Replacement Prosthesis – Product Status 55

Promontory Anchored Incus Replacement Prosthesis – Product Description 55

University of Utah Pipeline Products & Ongoing Clinical Trials Overview 56

Microphone Cochlear Implant – Product Status 56

Microphone Cochlear Implant – Product Description 56

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 57

Cochlear Implant – Product Status 57

Cochlear Implant – Product Description 57

List of Figures

Hearing Implants – Pipeline Products by Stage of Development 10

Hearing Implants – Pipeline Products by Segment 11

Hearing Implants – Pipeline Products by Territory 12

Hearing Implants – Pipeline Products by Regulatory Path 13

Hearing Implants – Pipeline Products by Estimated Approval Date 14

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports